Streptomyces griseus: Difference between revisions
No edit summary |
No edit summary |
||
| Line 24: | Line 24: | ||
=====Proteomics===== | =====Proteomics===== | ||
=====Protocols===== | =====Protocols===== | ||
<em>Escherichia coli</em> IR539 can be used to prepare plasmids mimicking the methylation profile of <em>Streptomyces griseus</em> to improve the transformation efficiency. | |||
Suzuki <em>et al</em>. 2011. Improvement of transformation efficiency by strategic circumvention of restriction barriers in <em>Streptomyces griseus</em>. J. Microbiol. Biotechnol. 21: 675-678. | |||
====Availability==== | ====Availability==== | ||
=====Culture Collections===== | =====Culture Collections===== | ||
Revision as of 23:29, 30 August 2019
Organism Page
Streptomyces griseus
Background
Streptomyces griseus is the producer of streptomycin, the first remedy for tuberculosis. Its first complete genome sequence was reported in 2008. S. griseus is also known for its production of an extracellular signalling molecule, A-factor, which turns on both morphological development and secondary metabolite production including streptomycin.
Growth & Maintenance
S. griseus grows well on YMPD agar and liquid media.
Sporulation
S. griseus sporulates well on YMPD agar medium.
Strains
Streptomyces griseus IFO 13350
Links
Genomes
Transcriptomes
Proteomics
Protocols
Escherichia coli IR539 can be used to prepare plasmids mimicking the methylation profile of Streptomyces griseus to improve the transformation efficiency.
Suzuki et al. 2011. Improvement of transformation efficiency by strategic circumvention of restriction barriers in Streptomyces griseus. J. Microbiol. Biotechnol. 21: 675-678.
